These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22528748)

  • 1. Comparison of caspase-3 activation in tumor cells upon treatment of chemotherapeutic drugs using capillary electrophoresis.
    Sha S; Jin H; Li X; Yang J; Ai R; Lu J
    Protein Cell; 2012 May; 3(5):392-9. PubMed ID: 22528748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput ratio imaging to profile caspase activity: potential application in multiparameter high content apoptosis analysis and drug screening.
    Joseph J; Seervi M; Sobhan PK; Retnabai ST
    PLoS One; 2011; 6(5):e20114. PubMed ID: 21637712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.
    Lacour S; Hammann A; Wotawa A; Corcos L; Solary E; Dimanche-Boitrel MT
    Cancer Res; 2001 Feb; 61(4):1645-51. PubMed ID: 11245478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation.
    Stepczynska A; Lauber K; Engels IH; Janssen O; Kabelitz D; Wesselborg S; Schulze-Osthoff K
    Oncogene; 2001 Mar; 20(10):1193-202. PubMed ID: 11313863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK; Schadendorf D; Röckmann H
    Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions.
    Eischen CM; Kottke TJ; Martins LM; Basi GS; Tung JS; Earnshaw WC; Leibson PJ; Kaufmann SH
    Blood; 1997 Aug; 90(3):935-43. PubMed ID: 9242521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL-induced apoptosis proceeding from caspase-3-dependent and -independent pathways in distinct HeLa cells.
    Lin J; Zhang Z; Zeng S; Zhou S; Liu BF; Liu Q; Yang J; Luo Q
    Biochem Biophys Res Commun; 2006 Aug; 346(4):1136-41. PubMed ID: 16793016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.
    Milner AE; Palmer DH; Hodgkin EA; Eliopoulos AG; Knox PG; Poole CJ; Kerr DJ; Young LS
    Cell Death Differ; 2002 Mar; 9(3):287-300. PubMed ID: 11859411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
    Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS
    Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3.
    Rehm M; Dussmann H; Janicke RU; Tavare JM; Kogel D; Prehn JH
    J Biol Chem; 2002 Jul; 277(27):24506-14. PubMed ID: 11964393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency.
    Helmbach H; Kern MA; Rossmann E; Renz K; Kissel C; Gschwendt B; Schadendorf D
    J Invest Dermatol; 2002 Jun; 118(6):923-32. PubMed ID: 12060385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells.
    Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG
    Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
    Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo.
    Shankar S; Chen X; Srivastava RK
    Prostate; 2005 Feb; 62(2):165-86. PubMed ID: 15389801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.
    Ballestrero A; Nencioni A; Boy D; Rocco I; Garuti A; Mela GS; Van Parijs L; Brossart P; Wesselborg S; Patrone F
    Clin Cancer Res; 2004 Feb; 10(4):1463-70. PubMed ID: 14977850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of cathepsin D in chemotherapy-induced cytochrome c release, caspase activation, and cell death.
    Emert-Sedlak L; Shangary S; Rabinovitz A; Miranda MB; Delach SM; Johnson DE
    Mol Cancer Ther; 2005 May; 4(5):733-42. PubMed ID: 15897237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine.
    Tian H; Ip L; Luo H; Chang DC; Luo KQ
    Br J Pharmacol; 2007 Feb; 150(3):321-34. PubMed ID: 17179946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of caspase-3 activation in single cells by fluorescence resonance energy transfer during photodynamic therapy induced apoptosis.
    Wu Y; Xing D; Luo S; Tang Y; Chen Q
    Cancer Lett; 2006 Apr; 235(2):239-47. PubMed ID: 15958279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.